Cleared Traditional

K221499 - Minimally Invasive Prostate Surgery Navigation System (FDA 510(k) Clearance)

Nov 2022
Decision
183d
Days
Class 2
Risk

K221499 is an FDA 510(k) clearance for the Minimally Invasive Prostate Surgery Navigation System. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Augment Intelligent Medical System (China) Co., Ltd. (Nanjing, CN). The FDA issued a Cleared decision on November 22, 2022, 183 days after receiving the submission on May 23, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K221499 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2022
Decision Date November 22, 2022
Days to Decision 183 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050